Vimarsana
Biggest News Aggregation in the World

Page 8 - Biosolutions Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosolutions Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosolutions Inc Today - Breaking & Trending Today

Cost of over-the-counter Narcan could be barrier to use - Vimarsana News

Cost of over-the-counter Narcan could be barrier to use

(The Center Square) – The U.S. Food and Drug Administration's decision to give an opioid overdose antidote over-the-counter status could help as illicit fentanyl floods of the nation's illegal drug

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket - Vimarsana News

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

Gainers LogicMark, Inc. (NASDAQ:LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin gr...

US approves sale of overdose reversal drug without prescription - Vimarsana News

US approves sale of overdose reversal drug without prescription

The decision comes as a bid to widen access to the life-saving drug as the US struggles with a wave of overdose deaths.

Emergent BioSolutions (NYSE:EBS) Shares Gap Down on Disappointing Earnings - Vimarsana News

Emergent BioSolutions (NYSE:EBS) Shares Gap Down on Disappointing Earnings

Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) gapped down before the market opened on Tuesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $14.00, but opened at $13.27. Emergent BioSolutions shares last traded at $12.15, with a volume of 395,192 shares traded. The biopharmaceutical company reported ($0.31) earnings […]

Health News Roundup: Moderna CEO to testify in senate on proposed vaccine price hike; WHO maintains public health emergency alert for mpox and more - Vimarsana News

Health News Roundup: Moderna CEO to testify in senate on proposed vaccine price hike; WHO maintains public health emergency alert for mpox and more

The Justice Department's court filing said the United States should be liable for any infringement of Arbutus Biopharma Corp and Genevant Sciences GmbH's patents that took place under Moderna's contract to provide shots for the government's nationwide vaccination effort. Explainer-Bird flu: what are the risks to people and animals? Countries ranging from the United States and Britain to France and Japan have suffered record losses of poultry in outbreaks of avian flu in the past year.